{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:48:59Z","timestamp":1790077739622,"version":"4.0.1"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0173530","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T17:55:34Z","timestamp":1489427734000},"page":"e0173530","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4336-9468","authenticated-orcid":true,"given":"Aizati N. A.","family":"Daud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorieke E. H.","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika P.","family":"Oktora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelmina S.","family":"Kerstjens-Frederikse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk","family":"Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens H.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eelko","family":"Hak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Wilffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/1061186X.2012.716847","article-title":"Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure","volume":"20","author":"F Staud","year":"2012","journal-title":"J Drug Target"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.placenta.2012.01.008","article-title":"Placental drug transporters and their role in fetal protection","volume":"33","author":"M Iqbal","year":"2012","journal-title":"Placenta. Elsevier Ltd"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1476-5381.2009.00336.x","article-title":"Drug transporters in the human blood-placental barrier","volume":"158","author":"K V\u00e4h\u00e4kangas","year":"2009","journal-title":"Br J Pharmacol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1517\/17425250903304049","article-title":"Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues","volume":"5","author":"P Myllynen","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejps.2005.11.002","article-title":"The role of transporters in drug interactions","volume":"27","author":"CJ Endres","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.bcp.2005.03.030","article-title":"Role of P-glycoprotein in transplacental transfer of methadone","volume":"69","author":"T Nanovskaya","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1124\/dmd.107.019448","article-title":"Role of the multidrug transporter proteins ABCB1 and ABCC2 in the diaplacental transport of talinolol in the term human placenta","volume":"36","author":"K May","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"ref8","article-title":"Functional role of p-glycoprotein and binding protein effect on the placental transfer of lopinavir\/ritonavir in the ex vivo human perfusion model","author":"P-F Ceccaldi","year":"2009","journal-title":"Obstet Gynecol Int"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.clpt.2005.04.014","article-title":"Functional role of P-glycoprotein in the human blood-placental barrier","volume":"78","author":"M M\u00f6ls\u00e4","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0301-2115(02)00513-4","article-title":"Lack of interaction of digoxin and P-glycoprotein inhibitors, quinidine and verapamil in human placenta in vitro","volume":"109","author":"G Holcberg","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s40264-015-0299-3","article-title":"P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study","volume":"38","author":"ANA Daud","year":"2015","journal-title":"Drug Saf. Springer International Publishing"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2217\/pgs.11.44","article-title":"Transporter-mediated drug\u2013drug interactions","volume":"12","author":"F Muller","year":"2011","journal-title":"Pharmacogenomics"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1124\/pr.113.007518","article-title":"Transporters and drug-drug interactions: important determinants of drug disposition and effects","volume":"65","author":"J K\u00f6nig","year":"2013","journal-title":"Pharmacol Rev"},{"key":"ref14","unstructured":"EUROCAT Guide 1.3 and reference documents Instructions for the Registration and Surveillance of Congenital Anomalies (2005) [Internet]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.eurocat-network.eu\/content\/EUROCAT-Guide-1.3.pdf\" xlink:type=\"simple\">http:\/\/www.eurocat-network.eu\/content\/EUROCAT-Guide-1.3.pdf<\/ext-link>"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/erp.13.20","article-title":"The population-based prescription database IADB.nl: its development, usefulness in outcomes research and challenges","volume":"13","author":"ST Visser","year":"2013","journal-title":"Expert Rev Pharmacoeconomics Outcome Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jclinepi.2002.12.001","article-title":"Identifying parents in pharmacy data: a tool for the continuous monitoring of drug exposure to unborn children","volume":"57","author":"E Schirm","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2133\/dmpk.20.452","article-title":"Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies","volume":"20","author":"M Nishimura","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2133\/dmpk.23.22","article-title":"Tissue-specific mRNA expression profiles of human solute carrier transporter superfamilies","volume":"23","author":"M Nishimura","year":"2008","journal-title":"Drug Metab Pharmacokinet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2133\/dmpk.24.91","article-title":"Tissue-Specific mRNA Expression Profiles of Human Solute Carrier 35 Transporters","volume":"24","author":"M Nishimura","year":"2009","journal-title":"Drug Metab Pharmacokinet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1139\/y06-078","article-title":"Expression of breast cancer resistance protein (BCRP \/ ABCG2) in human placenta throughout gestation and at term before and after labor","volume":"84","author":"D Yeboah","year":"2006","journal-title":"Can J Physiol Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1124\/dmd.113.054072","article-title":"Effect of gestational age on mRNA and protein expression of polyspecific organic cation transporters during pregnancy","volume":"41","author":"N Lee","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2008.04.001","article-title":"Functional differences in steroid sulfate uptake of organic anion transporter 4 (OAT4) and organic anion transporting polypeptide 2B1 (OATP2B1) in human placenta","volume":"111","author":"B Ugele","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/03602532.2010.512293","article-title":"Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy","volume":"43","author":"L Hahnova-Cygalova","year":"2011","journal-title":"Drug Metab Rev"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1517\/17425255.2015.1005073","article-title":"Regulation of drug transporter expression and function in the placenta","volume":"11","author":"F Staud","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1074\/jbc.275.6.4507","article-title":"Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta","volume":"275","author":"SH Cha","year":"2000","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1210\/jcem.87.4.8431","article-title":"Characterization of an organic anion-transporting polypeptide (OATP-B) in human placenta","volume":"87","author":"M V St-Pierre","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12248-014-9668-6","article-title":"Role of the Breast Cancer Resistance Protein (ABCG2) in Drug Transport-An Update","volume":"17","author":"Q Mao","year":"2015","journal-title":"AAPS J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clpt.2005.05.011","article-title":"Transporters and drug therapy: Implications for drug disposition and disease","volume":"78","author":"RH Ho","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","article-title":"OATPs, OATs and OCTs: The organic anion and cation transporters of the SLCO and SLC22A gene superfamilies","volume":"165","author":"M Roth","year":"2012","journal-title":"Br J Pharmacol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00424-003-1089-9","article-title":"The SLC22 drug transporter family","volume":"447","author":"H Koepsell","year":"2004","journal-title":"Pflugers Arch"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/1389200043489171","article-title":"Placental drug transporters","volume":"5","author":"JD Unadkat","year":"2004","journal-title":"Curr Drug Metab"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00003088-200443080-00001","article-title":"Drug Transfer and Metabolism by the Human Placenta","volume":"43","author":"MR Syme","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.taap.2005.02.023","article-title":"Role of transporters in placental transfer of drugs","volume":"207","author":"V Ganapathy","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"KM Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1124\/dmd.110.033571","article-title":"The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies","volume":"38","author":"C Prouillac","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2012.00126","article-title":"Drug Interactions at the Human Placenta: What is the Evidence?","volume":"3","author":"M Rubinchik-Stern","year":"2012","journal-title":"Front Pharmacol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/FPC.0b013e32834300cc","article-title":"The effects of the SLCO2B1 c.1457C &gt; T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans","volume":"21","author":"J Imanaga","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/FPC.0b013e328302cd41","article-title":"OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine","volume":"18","author":"Z-J Wang","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1208\/s12248-013-9505-3","article-title":"A simplified PBPK modeling approach for prediction of pharmacokinetics of four primarily renally excreted and CYP3A metabolized compounds during pregnancy","volume":"15","author":"B Xia","year":"2013","journal-title":"AAPS J"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2165\/00002018-200528120-00007","article-title":"Clinical relevance of drug-drug interactions: A structured assessment procedure","volume":"28","author":"EN Van Roon","year":"2005","journal-title":"Drug Saf"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1124\/dmd.112.050245","article-title":"Drug metabolism and transport during pregnancy: How does drug disposition change during pregnancy and what are the mechanisms that cause such changes?","volume":"41","author":"N Isoherranen","year":"2013","journal-title":"Drug Metab Dispos"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0173530","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T14:45:52Z","timestamp":1589035552000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0173530"}},"subtitle":[],"editor":[{"given":"Hendrik W.","family":"van Veen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0173530","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,13]]}}}